Company news
Syntara Limited news in 2021
Syntara Limited's news releases, calls and decks from 2021, newest first.
Share Purchase Plan
December 20, 2021
Security Purchase Plan
November 24, 2021
FDA Clears PXS Cancer Drug for Phase 2 Liver Cancer Study
November 8, 2021
Appendix 4C Cash Flow Report
October 27, 2021
PXS Doses First Patient in Phase 2 Bone Marrow Cancer Trial
October 13, 2021
PXS Cleared to Progress to Phase 2 Bone Marrow Cancer Trial
October 4, 2021
Pharmaxis Treatment to Prevent Wound and Burns Scars Clears
August 30, 2021
PXS Grants Exclusive Option to Develop High Payload Inhaler
August 16, 2021
PXS Drug Decreases Tumour Burden in Liver Cancer Model
August 4, 2021
PXS Sells Australian Distribution Rights for A$2m
June 30, 2021
PXS Announces First Results in Bone Marrow Cancer Trial
June 29, 2021
Quarterly Activity Report
April 30, 2021
Appendix 4C - quarterly
April 30, 2021
Sale of Russian Distribution Rights
April 13, 2021
First Patient Enrolled - Clinical Trial for Cancer Treatment
February 21, 2021
Pharmaxis Exports CF Drug to US - US$3 Million Milestone
February 8, 2021
Quarterly Activity Report - December 2020
January 28, 2021